Marc Barritault

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Venues

Neuro-oncology advances

Neuro-oncology

Pediatric blood & cancer

Molecular diagnosis & therapy

Université Paris Diderot (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Université Paris Diderot Sep 01 2012 - Sep 30 2016

France

PHD

Publications

Ines Esparragosa Vazquez, Marc Sanson, Olivier L Chinot, Maxime Fontanilles, Romain Rivoirard, Laure Thomas-Maisonneuve, Stéphanie Cartalat, Emeline Tabouret, Romain Appay, Alice Bonneville-Levard, Amélie Darlix, David Meyronet, Marc Barritault, François Gueyffier, Laurent Remontet, Delphine Maucort-Boulch, Jérôme Honnorat, Caroline Dehais, Francois Ducray, null null
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network. Neuro-oncology advances 6 (1) (2024)
Ines Esparragosa Vazquez, Marc Sanson, Olivier L Chinot, Maxime Fontanilles, Romain Rivoirard, Laure Thomas-Maisonneuve, Stéphanie Cartalat, Emeline Tabouret, Romain Appay, Alice Bonneville-Levard, Amélie Darlix, David Meyronet, Marc Barritault, François Gueyffier, Laurent Remontet, Delphine Maucort-Boulch, Jérôme Honnorat, Caroline Dehais, Francois Ducray, null null
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network. Neuro-oncology advances 6 (1) (2024)
Didier Frappaz, Marc Barritault
Reply to Roesler et al. concerning the MEVITEM trial. Neuro-oncology 24 (7) (2022)
Didier Frappaz, Marc Barritault, Laure Montané, Florence Laigle-Donadey, Olivier Chinot, Emilie Le Rhun, Alice Bonneville-Levard, Andreas F Hottinger, David Meyronnet, Anne-Sophie Bidaux, Gwenaële Garin, David Pérol
MEVITEM-a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation. Neuro-oncology 23 (11) (2021)
Thiebaud Picart, Marc Barritault, Delphine Poncet, Lise-Prune Berner, Cristina Izquierdo, Emeline Tabouret, Dominique Figarella Branger, Ahmed Idbaïh, Franck Bielle, Véronique Bourg, Fanny Burel Vandenbos, Elizabeth Cohen-Jonathan Moyal, Emmanuelle Uro-Coste, Jacques Guyotat, Jérôme Honnorat, Mathieu Gabut, David Meyronet, François Ducray
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults. Neuro-oncology advances 3 (1) (2021)
Marc Barritault, Delphine Poncet, David Meyronet, Alexandre Vasiljevic, Jonathan Lopez, Françoise Descotes, Carmine Mottolese, Alexandre Basle, Mélanie Benoit-Janin, Daniel Pissaloux, Marie Karanian, Pierre-Paul Bringuier, Pierre Leblond
NTRK2 gene fusion and resistance mutation: Seventeen-year course of a paediatric glioma. Pediatric blood & cancer 68 (9) (2021)
David Bret, Valentin Chappuis, Delphine Poncet, François Ducray, Karen Silva, Fabrice Mion, Alexandre Vasiljevic, Carole Ferraro-Peyret, Carmine Mottolese, Pierre Leblond, Mathieu Gabut, Didier Frappaz, Nathalie Streichenberger, David Meyronet, Pierre-Paul Bringuier, Marc Barritault
A Multiplex Quantitative Reverse Transcription Polymerase Chain Reaction Assay for the Detection of KIAA1549-BRAF Fusion Transcripts in Formalin-Fixed Paraffin-Embedded Pilocytic Astrocytomas. Molecular diagnosis & therapy 23 (4) (2020)

Marc Barritault.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marc Barritault